XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total Dentsply Sirona Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Beginning Balance at Dec. 31, 2021 $ 4,997 $ 4,996 $ 3 $ 6,606 $ 1,514 $ (592) $ (2,535) $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 69 69     69      
Other comprehensive income (loss) (37) (37)       (37)    
Exercise of stock options 5 5   1     4  
Stock based compensation expense 11 11   11        
Funding of employee stock purchase plan 2 2   1     1  
Accelerated share repurchase (150) (150)   (30)     (120)  
Restricted stock unit distributions (6) (6)   (16)     10  
Cash dividends (27) (27)     (27)      
Ending Balance at Mar. 31, 2022 4,864 4,863 3 6,573 1,556 (629) (2,640) 1
Beginning Balance at Dec. 31, 2021 4,997 4,996 3 6,606 1,514 (592) (2,535) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 142              
Other comprehensive income (loss) (127)              
Ending Balance at Jun. 30, 2022 4,838 4,837 3 6,617 1,602 (719) (2,666) 1
Beginning Balance at Mar. 31, 2022 4,864 4,863 3 6,573 1,556 (629) (2,640) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 73 73     73      
Other comprehensive income (loss) (90) (90)       (90)    
Exercise of stock options 2 2   0     2  
Stock based compensation expense 16 16   16        
Accelerated share repurchase 0 0   30     (30)  
Restricted stock unit distributions (2) (2)   (3)     1  
Cash dividends (26) (26)     (26)      
Ending Balance at Jun. 30, 2022 4,838 4,837 3 6,617 1,602 (719) (2,666) 1
Beginning Balance at Dec. 31, 2022 3,812 3,811 3 6,629 456 (628) (2,649) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (23) (19)     (19)     (4)
Other comprehensive income (loss) 14 14       14    
Stock based compensation expense 17 17   17        
Funding of employee stock purchase plan 3 3         3  
Accelerated share repurchase (151) (151)   (30)     (121)  
Restricted stock unit distributions (4) (4)   (12)     8  
Cash dividends (30) (30)     (30)      
Ending Balance at Mar. 31, 2023 3,638 3,641 3 6,604 407 (614) (2,759) (3)
Beginning Balance at Dec. 31, 2022 3,812 3,811 3 6,629 456 (628) (2,649) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 62              
Other comprehensive income (loss) 8              
Ending Balance at Jun. 30, 2023 3,702 3,706 3 6,648 463 (620) (2,788) (4)
Beginning Balance at Mar. 31, 2023 3,638 3,641 3 6,604 407 (614) (2,759) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 85 86     86     (1)
Other comprehensive income (loss) (6) (6)       (6)    
Exercise of stock options 1 1         1  
Stock based compensation expense 14 14   14        
Accelerated share repurchase 0 0   30     (30)  
Restricted stock unit dividends (1) (1)     (1)      
Cash dividends (29) (29)     (29)      
Ending Balance at Jun. 30, 2023 $ 3,702 $ 3,706 $ 3 $ 6,648 $ 463 $ (620) $ (2,788) $ (4)